Vasomedical Inc (VASO) 0.1533 $VASO
Vasomedical Announces Second Quarter 2016 Financial Results
ACCESSWIRE - Mon Aug 15, 8:00AM CDT
Revenue and Operating Income Grew Year-Over-Year by 68% and 28%, Respectively
Vasomedical to Report Second Quarter 2016 Results on August 15, 2016
ACCESSWIRE - Mon Aug 08, 8:01AM CDT
Management to Hold Investor Conference Call on August 15, 2016 at 11:00 a.m. ET
Vasomedical Announces First Quarter 2016 Financial Results
ACCESSWIRE - Fri May 13, 8:00AM CDT
Revenue Grew 135% Year-over-Year; Adjusted EBITDA Improved to $0.71 Million
Vasomedical to Report First Quarter 2016 Results on May 13, 2016
ACCESSWIRE - Fri May 06, 8:00AM CDT
Management to Hold Investor Conference Call on May 13, 2016 at 10:00 a.m. ET
Vasomedical Announces Financial Results for Fourth Quarter and Full Year for 2015
ACCESSWIRE - Tue Mar 29, 8:00AM CDT
Net Income Increased 239% to $3.8 Million; Adjusted EBITDA Increased 205% to $5.8 Million on Record Revenue
Vasomedical to Report Fourth Quarter and Fiscal Year 2015 Results on March 29, 2016
ACCESSWIRE - Tue Mar 22, 8:00AM CDT
Management to Hold Investor Conference Call on March 29, 2016 at 10:00 a.m. ET
Shawl Lobree Joins Vasomedical As President of VasoHealthcare
ACCESSWIRE - Wed Jan 06, 8:00AM CST
PLAINVIEW, NY / ACCESSWIRE / January 6, 2016 / Vasomedical, Inc. ("Vasomedical"
(OTC: VASO) today announced the appointment of Shawl Lobree as President of Vaso Diagnostics, Inc. d/b/a/ VasoHealthcare, a wholly owned subsidiary of Vasomedical, effective January 1, 2016. VasoHealthcare has since July 1, 2010 been the exclusive representative for the sale of select GE Healthcare Diagnostic Imaging products to specific market segments in the 48 contiguous states of the United States and the District of Columbia. GE Healthcare ("GEHC" is the healthcare business of General Electric Company (NYSE: GE).
GE: 31.25 (-0.18), MDSY: 1.46 (+0.01)
Vasomedical Named on the 2015 Technology Fast 500 List by Deloitte Four Years in a Row
ACCESSWIRE - Mon Nov 16, 8:01AM CST
PLAINVIEW, NY / ACCESSWIRE / November 16, 2015 / Vasomedical, Inc. ("Vasomedical" (OTC BB: VASO) today announced that it has been named on the Deloitte's Technology Fast 500(TM) list for the fourth consecutive year.
Vasomedical Announces Third Quarter 2015 Results
Marketwired - Thu Nov 12, 8:00AM CST
Vasomedical, Inc. ("Vasomedical" (OTC PINK: VASO) today reported its operating results for the three months ended September 30, 2015.
Vasomedical to Report Third Quarter 2015 Results on November 12, 2015
ACCESSWIRE - Thu Nov 05, 8:00AM CST
Management to Hold Investor Conference Call on November 12, 2015 at 2:00 p.m. ET
Vasomedical Announces Relocation of Corporate Office
ACCESSWIRE - Fri Sep 25, 8:01AM CDT
WESTBURY, NY / ACCESSWIRE / September 25, 2015 / Vasomedical, Inc. ("Vasomedical" (PINKSHEETS: VASO) today announced the relocation of its corporate office, effective Monday, September 28, 2015, to 137 Commercial Street, Plainview, NY 11803. In addition to the headquarters, this facility at Plainview, Long Island will also house the operations of Vasomedical Solutions, Inc. and the New York offices of NetWolves Network Services, both of which are wholly owned subsidiaries of Vasomedical, Inc.
Multiparameter Patient Monitoring Pipeline Review 2015 - Reviews the Major Players Involved in the Development of Multiparameter Patient Monitoring
M2 - Fri Aug 14, 8:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mtjj3r/multiparameter) has announced the addition of the "Multiparameter Patient Monitoring - Pipeline Review, 2015" report to their offering. Summary This Medical Devices sector report, Multiparameter Patient Monitoring - Pipeline Review, 2015" provides an overview of Multiparameter Patient Monitoring devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Multiparameter Patient Monitoring pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Our team of industry experts. Scope - Extensive coverage of the Multiparameter Patient Monitoring products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 List of Tables and List of Figures 2 Introduction 3 Products under Development 4 Multiparameter Patient Monitoring - Pipeline Products under Development by Companies 5 Multiparameter Patient Monitoring Companies and Product Overview 6 Multiparameter Patient Monitoring- Recent Developments 7 Appendix Companies Mentioned - Azoi Inc. - Bio-Impedance General Ltd. - BioNovus Technologies, LLC - Biovotion AG - Chinese University of Hong Kong - CorTronix Biomedical Advancement Technologies, Inc. - EarlySense, Inc. - Edwards Lifesciences Corporation - Fraunhofer-Institut fur Integrierte Schaltungen - Hope College - iHealth Lab Inc - Institute for Infocomm Research - Intelesens Ltd. - Kyushu University - LifeWatch Technologies, Ltd. - Monitor-it S.A. - NeMoDevices AG - PneumoSonics Inc. - Quanttus, Inc - REALTROMINS, Inc - Rice University - Scanadu HQ - Snap40 Limited - Sotera Wireless, Inc. - Sphere Medical Limited - Toshiba Medical Systems Corporation - University of Illinois - University of Oxford - University of Technology Sydney - University of Washington - Vasomedical, Inc. - Vios Medical, Inc. - Worcester Polytechnic Institute For more information visit http://www.researchandmarkets.com/research/mt...iparameter
EW: 118.07 (+3.12)
Vasomedical Announces Second Quarter 2015 Results
Marketwired - Thu Aug 13, 8:00AM CDT
Vasomedical, Inc. ("Vasomedical" (OTCBB: VASO) today reported its operating results for the three months ended June 30, 2015.
Vasomedical Acquires Network Service Company NetWolves
ACCESSWIRE - Mon Jun 01, 8:01AM CDT
Further Diversifying Operations and Enhancing the Healthcare IT Segment
Vasomedical to Report Fourth Quarter and Fiscal Year 2014 Results on March 30, 2015
ACCESSWIRE - Mon Mar 23, 8:00AM CDT
Management to Hold Investor Conference Call on March 30, 2015 at 11:00 a.m. ET
Vasomedical, Inc. Announces Extension of Exclusive Sales Representation Agreement with GE Healthcare Through 2018
ACCESSWIRE - Wed Jan 07, 8:01AM CST
WESTBURY, NY / ACCESSWIRE / January 7, 2015 / Vasomedical, Inc. (OTCBB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products, today announces the amendment of the sales representation agreement between its subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare, and GE Healthcare ("GEHC" , the healthcare business unit of General Electric Company (NYSE: GE), originally signed on May 19, 2010.
GE: 31.25 (-0.18)
Vasomedical Ranked Number 166 in Deloitte's 2014 Technology Fast 500(TM)
ACCESSWIRE - Thu Nov 13, 9:31AM CST
WESTBURY, NY / ACCESSWIRE / November 13, 2014 / Vasomedical, Inc. (OTCQB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices, today announced that, for the third consecutive year, it has been named on the Deloitte's Technology Fast 500(TM) list, with a ranking of 166, up from 207 last year.
Vasomedical Announces Second Quarter 2016 Financial Results
ACCESSWIRE - Mon Aug 15, 8:00AM CDT
Revenue and Operating Income Grew Year-Over-Year by 68% and 28%, Respectively
Vasomedical to Report Second Quarter 2016 Results on August 15, 2016
ACCESSWIRE - Mon Aug 08, 8:01AM CDT
Management to Hold Investor Conference Call on August 15, 2016 at 11:00 a.m. ET
Vasomedical Announces First Quarter 2016 Financial Results
ACCESSWIRE - Fri May 13, 8:00AM CDT
Revenue Grew 135% Year-over-Year; Adjusted EBITDA Improved to $0.71 Million
Vasomedical to Report First Quarter 2016 Results on May 13, 2016
ACCESSWIRE - Fri May 06, 8:00AM CDT
Management to Hold Investor Conference Call on May 13, 2016 at 10:00 a.m. ET
Vasomedical Announces Financial Results for Fourth Quarter and Full Year for 2015
ACCESSWIRE - Tue Mar 29, 8:00AM CDT
Net Income Increased 239% to $3.8 Million; Adjusted EBITDA Increased 205% to $5.8 Million on Record Revenue
Vasomedical to Report Fourth Quarter and Fiscal Year 2015 Results on March 29, 2016
ACCESSWIRE - Tue Mar 22, 8:00AM CDT
Management to Hold Investor Conference Call on March 29, 2016 at 10:00 a.m. ET
Shawl Lobree Joins Vasomedical As President of VasoHealthcare
ACCESSWIRE - Wed Jan 06, 8:00AM CST
PLAINVIEW, NY / ACCESSWIRE / January 6, 2016 / Vasomedical, Inc. ("Vasomedical"
(OTC: VASO) today announced the appointment of Shawl Lobree as President of Vaso Diagnostics, Inc. d/b/a/ VasoHealthcare, a wholly owned subsidiary of Vasomedical, effective January 1, 2016. VasoHealthcare has since July 1, 2010 been the exclusive representative for the sale of select GE Healthcare Diagnostic Imaging products to specific market segments in the 48 contiguous states of the United States and the District of Columbia. GE Healthcare ("GEHC" is the healthcare business of General Electric Company (NYSE: GE). GE: 31.25 (-0.18), MDSY: 1.46 (+0.01)
Vasomedical Named on the 2015 Technology Fast 500 List by Deloitte Four Years in a Row
ACCESSWIRE - Mon Nov 16, 8:01AM CST
PLAINVIEW, NY / ACCESSWIRE / November 16, 2015 / Vasomedical, Inc. ("Vasomedical"
(OTC BB: VASO) today announced that it has been named on the Deloitte's Technology Fast 500(TM) list for the fourth consecutive year. Vasomedical Announces Third Quarter 2015 Results
Marketwired - Thu Nov 12, 8:00AM CST
Vasomedical, Inc. ("Vasomedical"
(OTC PINK: VASO) today reported its operating results for the three months ended September 30, 2015. Vasomedical to Report Third Quarter 2015 Results on November 12, 2015
ACCESSWIRE - Thu Nov 05, 8:00AM CST
Management to Hold Investor Conference Call on November 12, 2015 at 2:00 p.m. ET
Vasomedical Announces Relocation of Corporate Office
ACCESSWIRE - Fri Sep 25, 8:01AM CDT
WESTBURY, NY / ACCESSWIRE / September 25, 2015 / Vasomedical, Inc. ("Vasomedical"
(PINKSHEETS: VASO) today announced the relocation of its corporate office, effective Monday, September 28, 2015, to 137 Commercial Street, Plainview, NY 11803. In addition to the headquarters, this facility at Plainview, Long Island will also house the operations of Vasomedical Solutions, Inc. and the New York offices of NetWolves Network Services, both of which are wholly owned subsidiaries of Vasomedical, Inc. Multiparameter Patient Monitoring Pipeline Review 2015 - Reviews the Major Players Involved in the Development of Multiparameter Patient Monitoring
M2 - Fri Aug 14, 8:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mtjj3r/multiparameter) has announced the addition of the "Multiparameter Patient Monitoring - Pipeline Review, 2015" report to their offering. Summary This Medical Devices sector report, Multiparameter Patient Monitoring - Pipeline Review, 2015" provides an overview of Multiparameter Patient Monitoring devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Multiparameter Patient Monitoring pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Our team of industry experts. Scope - Extensive coverage of the Multiparameter Patient Monitoring products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 List of Tables and List of Figures 2 Introduction 3 Products under Development 4 Multiparameter Patient Monitoring - Pipeline Products under Development by Companies 5 Multiparameter Patient Monitoring Companies and Product Overview 6 Multiparameter Patient Monitoring- Recent Developments 7 Appendix Companies Mentioned - Azoi Inc. - Bio-Impedance General Ltd. - BioNovus Technologies, LLC - Biovotion AG - Chinese University of Hong Kong - CorTronix Biomedical Advancement Technologies, Inc. - EarlySense, Inc. - Edwards Lifesciences Corporation - Fraunhofer-Institut fur Integrierte Schaltungen - Hope College - iHealth Lab Inc - Institute for Infocomm Research - Intelesens Ltd. - Kyushu University - LifeWatch Technologies, Ltd. - Monitor-it S.A. - NeMoDevices AG - PneumoSonics Inc. - Quanttus, Inc - REALTROMINS, Inc - Rice University - Scanadu HQ - Snap40 Limited - Sotera Wireless, Inc. - Sphere Medical Limited - Toshiba Medical Systems Corporation - University of Illinois - University of Oxford - University of Technology Sydney - University of Washington - Vasomedical, Inc. - Vios Medical, Inc. - Worcester Polytechnic Institute For more information visit http://www.researchandmarkets.com/research/mt...iparameter
EW: 118.07 (+3.12)
Vasomedical Announces Second Quarter 2015 Results
Marketwired - Thu Aug 13, 8:00AM CDT
Vasomedical, Inc. ("Vasomedical"
(OTCBB: VASO) today reported its operating results for the three months ended June 30, 2015. Vasomedical Acquires Network Service Company NetWolves
ACCESSWIRE - Mon Jun 01, 8:01AM CDT
Further Diversifying Operations and Enhancing the Healthcare IT Segment
Vasomedical to Report Fourth Quarter and Fiscal Year 2014 Results on March 30, 2015
ACCESSWIRE - Mon Mar 23, 8:00AM CDT
Management to Hold Investor Conference Call on March 30, 2015 at 11:00 a.m. ET
Vasomedical, Inc. Announces Extension of Exclusive Sales Representation Agreement with GE Healthcare Through 2018
ACCESSWIRE - Wed Jan 07, 8:01AM CST
WESTBURY, NY / ACCESSWIRE / January 7, 2015 / Vasomedical, Inc. (OTCBB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products, today announces the amendment of the sales representation agreement between its subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare, and GE Healthcare ("GEHC"
, the healthcare business unit of General Electric Company (NYSE: GE), originally signed on May 19, 2010. GE: 31.25 (-0.18)
Vasomedical Ranked Number 166 in Deloitte's 2014 Technology Fast 500(TM)
ACCESSWIRE - Thu Nov 13, 9:31AM CST
WESTBURY, NY / ACCESSWIRE / November 13, 2014 / Vasomedical, Inc. (OTCQB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices, today announced that, for the third consecutive year, it has been named on the Deloitte's Technology Fast 500(TM) list, with a ranking of 166, up from 207 last year.
